Inhibrx Biosciences (INBX) Stock Insights
INBX$73.29-22.37 -23.38%
$1.08B
Market Cap
-10.52
P/E
27.45
Forward P/E
69
Score
Inhibrx Biosciences (INBX) Stock Insights
INBX price $73.29 -22.37 -23.38%
- Ticker
- INBX
- Price
- $73.29
- Change
- -22.37 -23.38%
- Market cap ?
- $1.08B
- P/E ?
- -10.52
- Forward P/E ?
- 27.45
- Dividend yield ?
- 0.00%
- Beta ?
- 3.82
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 69
- Value
- 49
- Quality
- 58
- Growth
- 100
Stocklytics score rationale: value 49, quality 58, growth 100.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 6667000 | 8391000 | 8595000 | 9093000 | 12808000 | 7125000 | 2192000 | 1800000 | 200000 | 1300000 |
Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is…
Fair value
INBX fair value $52.92. Price $73.29. Price is 39% above fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 152.02K. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 2.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 14.72M. Net debt -17.21M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-13 | — | -2.45 | — | 1.90M |
| 2026-08-13 | -2.34 | -2.28 | — | — |
| 2026-05-14 | -2.15 | -2.37 | — | — |
| 2026-03-19 | -2.11 | -2.08 | — | 1.11M |
| 2025-11-14 | -2.28 | -2.08 | — | — |
| 2025-08-13 | -1.85 | -2.92 | 1.30M | — |
| 2025-05-14 | -2.80 | -2.55 | — | — |
| 2025-03-17 | -3.09 | -2.88 | 100.00K | — |
| 2024-11-14 | -2.84 | -3.06 | — | — |
| 2024-08-13 | 125.48 | -3.60 | 100.00K | — |
| 2024-06-03 | -1.44 | -1.04 | — | 50.00K |
| 2024-02-28 | -1.73 | -1.07 | 1.63M | 50.00K |
| 2023-11-09 | -1.10 | -1.01 | 119.00K | 50.00K |
| 2023-08-07 | -1.08 | -1.02 | 30.00K | — |
| 2023-05-08 | -1.12 | -0.84 | 17.00K | 150.00K |
| 2023-03-06 | -0.95 | -0.80 | 274.00K | 994.00K |
| 2022-11-07 | -0.90 | -1.01 | 278.00K | 633.33K |
| 2022-08-08 | -0.97 | -0.84 | 711.00K | 1.07M |
| 2022-05-09 | -0.80 | -0.62 | 915.00K | 1.10M |
| 2022-02-28 | -0.55 | -0.53 | 2.84M | 1.21M |
| 2021-11-09 | -0.54 | -0.57 | 2.51M | 1.50M |
| 2021-08-09 | -0.55 | -0.51 | 918.00K | 820.00K |
| 2021-05-13 | -0.51 | -0.61 | 863.00K | 1.01M |
| 2021-03-12 | -0.47 | -0.50 | 2.78M | — |
| 2020-11-13 | -0.77 | -0.60 | 5.83M | — |
| 2020-08-19 | -0.70 | — | 872.00K | — |
| 2020-06-30 | -0.50 | — | 3.33M | — |
| 2019-12-31 | -0.57 | — | 267.00K | — |
| 2019-09-30 | -0.70 | — | 794.00K | — |
| 2019-06-30 | -0.39 | — | 1.00M | — |
| 2019-03-31 | -0.13 | — | 7.03M | — |
| 2018-12-31 | -0.24 | — | 2.27M | — |
| 2018-06-30 | -0.25 | — | 2.50M | — |
| 2018-03-31 | -0.32 | — | 2.50M | — |
| 2017-12-31 | -0.44 | — | 281.00K | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency Irregular.
Safety score 43/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. Dividend history is short. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| 2024-05-30 | $0.85 | 2024-05-30 | 2024-06-20 | Irregular |
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-14 | Lappe Mark | Buy | 100 | $85.76 | 8.58K |
| 2026-10-14 | Lappe Mark | Buy | 2.47K | $85.00 | 209.95K |
| 2026-10-14 | Lappe Mark | Buy | 2.47K | $84.07 | 207.65K |
| 2026-10-14 | Lappe Mark | Buy | 100 | $85.76 | 8.58K |
| 2026-10-14 | Lappe Mark | Buy | 2.45K | $85.00 | 208.33K |
| 2026-10-14 | Lappe Mark | Buy | 2.45K | $84.07 | 205.89K |
| 2026-09-28 | Lappe Mark | Buy | 3.00K | $101.70 | 305.11K |
| 2026-09-28 | Lappe Mark | Buy | 1.50K | $98.88 | 148.32K |
| 2026-09-25 | Lappe Mark | Buy | 2.18K | $99.60 | 216.73K |
| 2026-09-25 | Lappe Mark | Buy | 3.32K | $98.87 | 328.63K |
| 2026-09-23 | Kayyem Jon Faiz | Buy | 5.00K | $100.00 | 500.00K |
| 2026-09-16 | Kayyem Jon Faiz | Buy | 5.00K | $100.00 | 500.00K |
| 2026-09-15 | MANHARD KIMBERLY | Sell | 500 | $105.05 | 52.52K |
| 2026-09-14 | MANHARD KIMBERLY | Sell | 500 | $110.26 | 55.13K |
| 2026-09-11 | MANHARD KIMBERLY | Sell | 500 | $111.78 | 55.89K |
| 2026-09-09 | MANHARD KIMBERLY | Sell | 500 | $115.80 | 57.90K |
| 2026-09-08 | MANHARD KIMBERLY | Sell | 500 | $115.14 | 57.57K |
| 2026-09-08 | Kayyem Jon Faiz | Buy | 5.00K | $113.52 | 567.58K |
| 2026-09-08 | FORSYTH DOUGLAS | Buy | 2.50K | $114.65 | 286.62K |
| 2026-09-08 | Lappe Mark | Buy | 9.68K | $112.28 | 1.09M |
| 2026-09-08 | Lappe Mark | Buy | 1.22K | $111.88 | 136.38K |
| 2026-09-08 | Lappe Mark | Buy | 500 | $108.23 | 54.12K |
| 2026-09-08 | Lappe Mark | Buy | 1.10K | $107.12 | 117.84K |
| 2026-09-08 | Lappe Mark | Buy | 6.61K | $100.64 | 664.72K |
| 2026-09-08 | Lappe Mark | Buy | 5.89K | $99.29 | 585.34K |
| 2026-06-03 | FORSYTH DOUGLAS | Buy | 10.00K | $95.22 | 952.20K |
| 2026-06-03 | Vuori Kristiina MD | Buy | 10.00K | $95.22 | 952.20K |
| 2026-06-03 | MANHARD KIMBERLY | Buy | 10.00K | $95.22 | 952.20K |
| 2026-06-03 | Kayyem Jon Faiz | Buy | 10.00K | $95.22 | 952.20K |
| 2026-06-03 | Vuori Kristiina MD | Buy | 15.00K | $95.22 | 1.43M |
| 2026-06-03 | Kayyem Jon Faiz | Buy | 15.00K | $95.22 | 1.43M |
| 2026-06-03 | FORSYTH DOUGLAS | Buy | 15.00K | $95.22 | 1.43M |
| 2026-06-03 | MANHARD KIMBERLY | Buy | 15.00K | $95.22 | 1.43M |
| 2026-04-24 | Matly David | Buy | 50.00K | $129.06 | 6.45M |
| 2025-10-07 | VIKING GLOBAL INVESTORS LP | Sell | 308.64K | $32.25 | 9.95M |
| 2025-10-07 | VIKING GLOBAL INVESTORS LP | Sell | 25.04K | $32.25 | 807.60K |
| 2025-10-07 | VIKING GLOBAL INVESTORS LP | Sell | 16.32K | $32.25 | 526.16K |
| 2025-05-28 | MANHARD KIMBERLY | Buy | 15.00K | $12.91 | 193.65K |
| 2025-05-28 | Vuori Kristiina MD | Buy | 15.00K | $12.91 | 193.65K |
| 2025-05-28 | Kayyem Jon Faiz | Buy | 15.00K | $12.91 | 193.65K |
| 2025-05-28 | FORSYTH DOUGLAS | Buy | 15.00K | $12.91 | 193.65K |
| 2025-04-01 | Deck Kelly | Buy | 15.00K | $14.05 | 210.75K |
| 2025-04-01 | Matly David | Buy | 50.00K | $14.05 | 702.50K |
| 2025-04-01 | Matly David | Other | 175.00K | $15.86 | 2.78M |
| 2025-03-27 | Kayyem Jon Faiz | Sell | 90.00K | — | — |
| 2024-12-16 | Kayyem Jon Faiz | Sell | 500.00K | — | — |
| 2024-12-16 | Kayyem Jon Faiz | Buy | 250.00K | — | — |
| 2024-12-06 | Kayyem Jon Faiz | Sell | 52.00K | — | — |
| 2024-11-20 | Kayyem Jon Faiz | Buy | 18.75K | $14.19 | 266.10K |
| 2024-11-19 | Kayyem Jon Faiz | Buy | 34.84K | $14.23 | 495.71K |
| 2024-10-03 | Vuori Kristiina MD | Buy | 6.67K | $15.00 | 100.00K |
| 2024-09-16 | Lappe Mark | Buy | 13.04K | $17.13 | 223.32K |
| 2024-09-12 | Lappe Mark | Buy | 26.96K | $15.05 | 405.79K |
| 2024-09-11 | Vuori Kristiina MD | Buy | 6.46K | $15.07 | 97.31K |
| 2024-09-10 | Vuori Kristiina MD | Buy | 179 | $15.00 | 2.69K |
| 2024-09-10 | Lappe Mark | Buy | 8.50K | $15.19 | 129.12K |
| 2024-09-09 | Lappe Mark | Buy | 9.50K | $15.21 | 144.50K |
| 2024-09-06 | Lappe Mark | Buy | 26.00K | $15.29 | 397.54K |
| 2024-08-28 | MANHARD KIMBERLY | Buy | 10.00K | $13.98 | 139.80K |
| 2024-08-23 | FORSYTH DOUGLAS | Buy | 59.81K | $14.07 | 841.55K |
| 2024-08-22 | FORSYTH DOUGLAS | Buy | 15.19K | $12.89 | 195.77K |
| 2024-08-21 | Lappe Mark | Buy | 12.95K | $12.93 | 167.38K |
| 2024-08-20 | Lappe Mark | Buy | 27.05K | $12.97 | 350.90K |
| 2024-06-24 | Kayyem Jon Faiz | Sell | 89.05K | — | — |
| 2024-06-24 | Kayyem Jon Faiz | Buy | 10.00K | — | — |
| 2024-06-05 | Kayyem Jon Faiz | Buy | 8.27K | $17.89 | 147.86K |
| 2024-06-05 | Kayyem Jon Faiz | Buy | 49.28K | $17.23 | 849.16K |
| 2024-06-04 | Kayyem Jon Faiz | Buy | 23.73K | $18.24 | 432.76K |
| 2024-06-04 | Kayyem Jon Faiz | Buy | 65.34K | $17.44 | 1.14M |
| 2024-06-03 | Kayyem Jon Faiz | Buy | 80.74K | $17.90 | 1.45M |
| 2024-06-03 | Kayyem Jon Faiz | Buy | 46.79K | $16.61 | 777.22K |
| 2024-05-31 | Kayyem Jon Faiz | Buy | 70.19K | $16.14 | 1.13M |
| 2024-05-30 | VIKING GLOBAL INVESTORS LP | Sell | 1.04M | $0.00 | 104 |
| 2024-05-30 | VIKING GLOBAL INVESTORS LP | Sell | 511.63K | $30.00 | 15.35M |
| 2024-05-30 | Vuori Kristiina MD | Sell | 15.00K | $12.57 | 188.55K |
| 2024-05-30 | Vuori Kristiina MD | Sell | 30.00K | $40.45 | 1.21M |
| 2024-05-30 | Vuori Kristiina MD | Sell | 15.00K | $23.03 | 345.45K |
| 2024-05-30 | MANHARD KIMBERLY | Sell | 3.50K | $17.44 | 61.04K |
| 2024-05-30 | MANHARD KIMBERLY | Sell | 15.00K | $24.78 | 371.70K |
| 2024-05-30 | MANHARD KIMBERLY | Sell | 15.00K | $23.03 | 345.45K |
| 2024-05-30 | MANHARD KIMBERLY | Sell | 15.00K | $12.57 | 188.55K |
| 2024-05-30 | MANHARD KIMBERLY | Sell | 17.26K | $20.43 | 352.60K |
| 2024-05-30 | Lappe Mark | Sell | 100.00K | $23.30 | 2.33M |
| 2024-05-30 | Lappe Mark | Sell | 59.46K | $30.00 | 1.78M |
| 2024-05-30 | Lappe Mark | Sell | 145.00K | $33.63 | 4.88M |
| 2024-05-30 | Kayyem Jon Faiz | Sell | 17.26K | $10.52 | 181.56K |
| 2024-05-30 | Kayyem Jon Faiz | Sell | 15.00K | $24.78 | 371.70K |
| 2024-05-30 | Kayyem Jon Faiz | Sell | 25.00K | $30.00 | 750.00K |
| 2024-05-30 | Kayyem Jon Faiz | Sell | 15.00K | $23.03 | 345.45K |
| 2024-05-30 | Kayyem Jon Faiz | Sell | 15.00K | $12.57 | 188.55K |
| 2024-05-30 | FORSYTH DOUGLAS | Sell | 15.00K | $12.57 | 188.55K |
| 2024-05-30 | FORSYTH DOUGLAS | Sell | 598.26K | $30.00 | 17.95M |
| 2024-05-30 | FORSYTH DOUGLAS | Sell | 17.26K | $10.52 | 181.56K |
| 2024-05-30 | FORSYTH DOUGLAS | Sell | 15.00K | $23.03 | 345.45K |
| 2024-05-30 | FORSYTH DOUGLAS | Sell | 15.00K | $24.78 | 371.70K |
| 2024-05-30 | Eckelman Brendan P. | Sell | 6.67K | $33.63 | 224.21K |
| 2024-05-30 | Eckelman Brendan P. | Sell | 160.00K | $30.00 | 4.80M |
| 2024-05-30 | Eckelman Brendan P. | Sell | 26.67K | $23.30 | 621.34K |
| 2024-05-30 | Deck Kelly | Sell | 9.17K | $34.16 | 313.14K |
| 2024-05-30 | Deck Kelly | Sell | 14.58K | $33.63 | 490.43K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 178, holders +31 vs prior quarter. Ownership 91.65%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| MORGAN STANLEY | 1.31M | 44.97K | +3.56% | 123.94M |
| PERCEPTIVE ADVISORS LLC | 1.30M | -144.94K | -10.05% | 122.96M |
| SANOFI | 1.16M | 0 | 0.00% | 109.71M |
| VIKING GLOBAL INVESTORS LP | 1.12M | -313.78K | -21.82% | 106.49M |
| HIGHTOWER ADVISORS, LLC | 870.55K | 351 | +0.04% | 82.48M |
| BANK OF AMERICA CORP /DE/ | 841.14K | 808.46K | +2473.63% | 79.70M |
| BLACKROCK, INC. | 825.97K | 27.07K | +3.39% | 78.26M |
| SCHONFELD STRATEGIC ADVISORS LLC | 697.59K | 442.76K | +173.75% | 66.10M |
| STATE STREET CORP | 640.46K | 89.61K | +16.27% | 60.68M |
| VANGUARD CAPITAL MANAGEMENT LLC | 492.48K | 6.05K | +1.24% | 46.66M |
| WOODLINE PARTNERS LP | 400.89K | 16.46K | +4.28% | 37.98M |
| CAPITAL RESEARCH GLOBAL INVESTORS | 363.05K | -29.80K | -7.58% | 34.40M |
| GOLDMAN SACHS GROUP INC | 338.18K | 271.68K | +408.54% | 32.04M |
| PFM HEALTH SCIENCES, LP | 308.38K | 2.95K | +0.97% | 29.22M |
| SOFINNOVA INVESTMENTS, INC. | 303.10K | -102.93K | -25.35% | 28.72M |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 271.70K | 101.00K | +59.17% | 25.74M |
| PARKMAN HEALTHCARE PARTNERS LLC | 256.95K | 256.95K | New | 24.35M |
| GEODE CAPITAL MANAGEMENT, LLC | 256.18K | 24.67K | +10.65% | 24.28M |
| FIRST TURN MANAGEMENT, LLC | 164.78K | 164.78K | New | 15.61M |
| MILLENNIUM MANAGEMENT LLC | 147.20K | -180.66K | -55.10% | 13.95M |
| CDC FINANCIAL, INC. | 140.13K | 78.13K | +126.02% | 13.28M |
| FIRST TRUST ADVISORS LP | 128.42K | 128.42K | New | 12.17M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 122.56K | 50.10K | +69.14% | 11.61M |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | 119.20K | -5.80K | -4.64% | 11.29M |
| NORTHERN TRUST CORP | 100.96K | 7.26K | +7.75% | 9.57M |
Insights · Dividends · Forecast · Financials · Learn